Elm Partners Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
VCM
VPM
Elm Partners Management's VRTX Position: Q1 2026 in Review
Elm Partners Management increased its Vertex Pharmaceuticals (VRTX) stake by 20% in Q1 2026, buying an estimated $49K and bringing the position to 636 shares worth $282K. The position accounts for 0.01% of the portfolio, ranked #131.
Elm Partners Management first reported a position in VRTX in Q3 2025 and has held it in 3 quarters since. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.
- Elm Partners Management held 636 shares of Vertex Pharmaceuticals worth $282K as of Q1 2026.
- Elm Partners Management bought 105 Vertex Pharmaceuticals shares in Q1 2026, an estimated $49K.
- Vertex Pharmaceuticals made up 0.01% of Elm Partners Management's portfolio in Q1 2026, its #131 holding.
- Elm Partners Management first reported a position in Vertex Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
- 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.
Based on Elm Partners Management's 13F filing for Q1 2026, filed 13 May 2026.